TURATO, CRISTIAN
 Distribuzione geografica
Continente #
NA - Nord America 1.379
AS - Asia 1.219
EU - Europa 698
SA - Sud America 251
AF - Africa 45
OC - Oceania 2
Totale 3.594
Nazione #
US - Stati Uniti d'America 1.340
SG - Singapore 367
CN - Cina 303
HK - Hong Kong 225
BR - Brasile 191
IT - Italia 158
RU - Federazione Russa 152
VN - Vietnam 141
DE - Germania 94
FR - Francia 81
IE - Irlanda 79
BD - Bangladesh 55
FI - Finlandia 46
GB - Regno Unito 32
IN - India 24
ZA - Sudafrica 20
CA - Canada 19
IQ - Iraq 19
AR - Argentina 18
JP - Giappone 14
SE - Svezia 12
TR - Turchia 12
MX - Messico 11
EC - Ecuador 9
VE - Venezuela 9
EG - Egitto 8
NL - Olanda 8
BE - Belgio 7
NP - Nepal 7
PK - Pakistan 7
SA - Arabia Saudita 7
CO - Colombia 6
KE - Kenya 6
BO - Bolivia 5
ES - Italia 5
CH - Svizzera 4
CL - Cile 4
ID - Indonesia 4
MA - Marocco 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AT - Austria 3
IL - Israele 3
OM - Oman 3
PE - Perù 3
PY - Paraguay 3
AZ - Azerbaigian 2
BG - Bulgaria 2
CI - Costa d'Avorio 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
JO - Giordania 2
KR - Corea 2
LT - Lituania 2
PH - Filippine 2
PS - Palestinian Territory 2
UA - Ucraina 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
CR - Costa Rica 1
CU - Cuba 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
GE - Georgia 1
IM - Isola di Man 1
JM - Giamaica 1
KG - Kirghizistan 1
KH - Cambogia 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MM - Myanmar 1
MT - Malta 1
MY - Malesia 1
NE - Niger 1
NR - Nauru 1
NZ - Nuova Zelanda 1
PA - Panama 1
PL - Polonia 1
PR - Porto Rico 1
QA - Qatar 1
RS - Serbia 1
SR - Suriname 1
SZ - Regno dello Swaziland 1
TL - Timor Orientale 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
Totale 3.594
Città #
San Jose 261
Hong Kong 224
Ashburn 166
Singapore 159
Dallas 115
Boardman 105
Chandler 94
Dublin 77
Beijing 64
Lauterbourg 62
Ho Chi Minh City 60
Los Angeles 52
Shanghai 52
Council Bluffs 48
Munich 48
New York 39
Redondo Beach 37
Moscow 36
Turku 29
Hanoi 28
Buffalo 23
Helsinki 17
Milan 17
San Francisco 17
São Paulo 17
Petrópolis 16
Frankfurt am Main 14
Pavia 14
Düsseldorf 13
Johannesburg 13
Orem 12
Brooklyn 11
Da Nang 11
Florence 11
Chicago 10
The Dalles 10
Tokyo 10
Boston 8
Chennai 8
Montreal 8
Nuremberg 8
Santa Clara 8
Stockholm 8
Baghdad 7
Brussels 7
Lawrence 7
Princeton 7
Rio de Janeiro 7
Brasília 6
Catania 6
Guangzhou 6
Mira 6
Nairobi 6
Padova 6
Ankara 5
Campinas 5
Houston 5
Kathmandu 5
Medford 5
Quito 5
Seattle 5
Washington 5
Wilmington 5
Atlanta 4
Denver 4
Dhaka 4
Haiphong 4
Manchester 4
Moncalieri 4
Osasco 4
Pescara 4
Porto Alegre 4
Travaco Siccomario 4
Turin 4
Zhengzhou 4
Biên Hòa 3
Des Moines 3
Giza 3
Guayaquil 3
Ha Long 3
Handan 3
Imbersago 3
La Paz 3
Mexico City 3
Nanjing 3
New Delhi 3
Niterói 3
Paris 3
Phoenix 3
Phủ Lý 3
Salvador 3
Santiago 3
Tashkent 3
Thái Nguyên 3
Tianjin 3
Toronto 3
Urbana 3
Valencia 3
Verona 3
Zurich 3
Totale 2.279
Nome #
Model-based analysis of patient-derived organoids for evaluating anticancer drugs 98
PD-L1 and IFN-γ modulate Non-Small Cell Lung Cancer (NSCLC) cell plasticity associated to immune checkpoint inhibitor (ICI)-mediated hyperprogressive disease (HPD) 89
Oncostatin M is overexpressed in NASH-related hepatocellular carcinoma and promotes cancer cell invasiveness and angiogenesis 88
Development, Expansion, and Histological Characterization of Patient-Derived Liver Organoids for Drug Screening and Disease Modeling 86
Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells 85
Patient-derived liver organoids as an in vitro model to study new personalized therapies targeting VDAC1 in intrahepatic cholangiocarcinoma 85
Hepatic ischemia induces a time-dependent increase in SERPINB3 gene expression 85
CARATTERIZZAZIONE BIOLOGICA E FUNZIONE DELLA NUOVA ISOFORMA SCCA-PD 83
From lichen to organoids: Usnic acid enantiomers show promise against Cholangiocarcinoma via MNK2 targeting and MAPK pathway modulation 80
Prone positioning is safe and may reduce the rate of intubation in selected covid-19 patients receiving high-flow nasal oxygen therapy 80
SERPINB3 modulates TGF-beta expression in chronic liver disease 80
VDAC1-interacting molecules promote cell death in cancer organoids through mitochondrial-dependent metabolic interference 79
SerpinB3 administration protects liver against ischemia-reperfusion injury 78
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma 70
Hepatic ischemia induces a time-dependent increase in SerpinB3 gene expression 69
SerpinB3 as a Pro-Inflammatory Mediator in the Progression of Experimental Non-Alcoholic Fatty Liver Disease 68
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis 67
Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment 66
Increased Th1 immune response in SERPINB3 transgenic mice during acute liver failure 64
Chronic Liver Disease: Latest Research in Pathogenesis, Detection and Treatment 59
High-flow nasal cannula oxygen therapy to treat acute respiratory failure in patients with acute exacerbation of idiopathic pulmonary fibrosis 59
Changes in gene expression of cytochrome P-450 in liver, kidney and aorta of cirrhotic rats 58
SCCA1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity 57
IgM-linked SerpinB3 and SerpinB4 in Sera of Patients with Chronic Liver Disease 56
Protocol for high-yield bacterial expression and purification of the voltage-dependent anion channel 1 for high-throughput biophysical assays 55
High-flow nasal cannula oxygen therapy to treat patients with hypoxemic acute respiratory failure consequent to SARS-CoV-2 infection 55
Epitope-Specific Anti-SerpinB3 Antibodies for SerpinB3 Recognition and Biological Activity Inhibition 54
Engineered EVs for Oxidative Stress Protection 53
Liver Organoids as an In Vitro Model to Study Primary Liver Cancer 53
Effect of a passive exhalation port on tracheostomy ventilation in amyotrophic lateral sclerosis patients: A randomized controlled trial 53
Characterization of the new isoform of squamous cell carcinoma antigen-1 (SCCA-PD) detected in hepatocellular carcinoma 52
HFE, TGF-BETA1 AND SQUAMOUS CELL CARCNOMA ANTIGEN-1 POLYMORPHISMS AND LIVER DISEASE STAGE IN CHRONIC HCV INFECTION 50
Inibitore di SerpinB3 per il trattamento della progressione di malattie croniche fibrosanti e di tumori primitivi 49
Hepatocellular Carcinoma: Latest Research in Pathogenesis, Detection and Treatment 49
The polymorphic variant of SerpinB3 (SerpinB3-PD) is associated with faster cirrhosis decompensation 47
ULTRAFINE GOLD NANOPARTICLES CONJUGATED WITH PRES1 PEPTIDE OF HEPATITIS B VIRUS ENVELOPE PROTEIN TARGETING HEPATOMA CELLS 47
Increased antiprotease activity of the SerpinB3 polymorphic variant SCCA-PD 46
Erratum: SERPINB3 is associated with longer survival in transgenic mice (Scientific Reports (2013) 3 (3056) DOI: 10.1038/srep03056) 46
SerpinB3 Upregulates Low-Density Lipoprotein Receptor-Related Protein (LRP) Family Members, Leading to Wnt Signaling Activation and Increased Cell Survival and Invasiveness 45
SerpinB3 promotes pro-fibrogenic responses in activated hepatic stellate cells 44
Binding and Uptake into Human Hepatocellular Carcinoma Cells of Peptide-Functionalized Gold Nanoparticles 44
Role of squamous cell carcinoma antigen-1 on liver cells after partial hepatectomy in transgenic mice 41
Hyaluronated and PEGylated Liposomes as a Potential Drug-Delivery Strategy to Specifically Target Liver Cancer and Inflammatory Cells 40
Hypoxia up-regulates SERPINB3 through HIF-2α in human liver cancer cells 40
Hepatic progenitor cells express SerpinB3 39
MiR-122 Targets SerpinB3 and Is Involved in Sorafenib Resistance in Hepatocellular Carcinoma 38
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection 37
SERPINB3 is associated with longer survival in transgenic mice 37
SERPINB3 protects from oxidative damage by chemotherapeutics through inhibition of mitochondrial respiratory complex I 37
The protease activated receptor 2 - CCAAT/enhancer-binding protein beta - SerpinB3 axis inhibition as a novel strategy for the treatment of non-alcoholic steatohepatitis 36
PreS1 peptide-functionalized gold nanostructures with SERRS tags for efficient liver cancer cell targeting 36
Serpinb3 is overexpressed in the liver in presence of iron overload 35
LEADING ROLE OF SERPINB3 IN MOLECULAR SIGNATURES OF WORSE PROGNOSIS IN HEPATOCELLULAR CARCINOMA 35
Low-Dose Acetylsalicylic Acid and Mitochondria-Targeted Antioxidant Mitoquinone Attenuate Non-Alcoholic Steatohepatitis in Mice 34
SerpinB3 and Yap Interplay Increases Myc Oncogenic Activity 34
Pirfenidone improves the survival of patients with idiopathic pulmonary fibrosis hospitalized for acute exacerbation 34
Semisolid Wet Sol–Gel Silica/Hydroxypropyl Methyl Cellulose Formulation for Slow Release of Serpin B3 Promotes Wound Healing In Vivo 33
Squamous cell carcinoma antigen-1 (SERPINB3) polymorphism in chronic liver disease 33
MODULATION OF P35 SIGNALING BY SERPINB3 UNDER GENOTOXIC CONDITIONS 33
ROLE OF MICROGLIAL ACTIVATION VIA SERPINB3 IN EXPERIMENTAL ACUTE HEPATIC ENCEPHALOPATY 32
MicroRNAs and SerpinB3 in hepatocellular carcinoma 31
Low p66shc with high serpinb3 levels favors necroptosis and better survival in hepatocellular carcinoma 30
Inhibition of Epoxyeicosatrienoic Acid Production in Rats With Cirrhosis Has Beneficial Effects on Portal Hypertension by Reducing Splanchnic Vasodilation 29
Over-expression of SERPINB3 in hepatoblastoma: A possible insight into the genesis of this tumour? 29
Nintedanib treatment for idiopathic pulmonary fibrosis patients who have been switched from pirfenidone therapy: A retrospective case series study 27
Increased myoendothelial gap junctions mediate the enhanced response to epoxyeicosatrienoic acid and acetylcholine in mesenteric arterial vessels of cirrhotic rats 27
Spontaneous pneumomediastinum complicating severe acute asthma exacerbation in adult patients 27
Non-Invasive Ventilation for Acute Respiratory Failure in Duchenne Muscular Dystrophy Patients 26
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets 26
New molecular targets for functionalized nanosized drug delivery systems in personalized therapy for hepatocellular carcinoma 26
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker 25
SERPINB3 (serpin peptidase inhibitor, clade B (ovalbumin), member 3) 24
Liver pro-oncogenic potential of SERPINB3 22
SerpinB3/Protease Activated Receptor-2 Axis Is Essential for SARS CoV-2 Infection 12
Inhibition of the SerpinB3/protease-activated receptor 2 axis reduces liver cancer development and affects lipid metabolism 7
Totale 3.683
Categoria #
all - tutte 19.949
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 19.949


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202229 0 0 0 0 0 0 0 1 2 2 8 16
2022/2023272 16 20 3 27 16 27 0 12 87 1 10 53
2023/2024328 14 71 24 19 42 50 35 7 2 8 23 33
2024/2025922 13 67 9 7 26 15 97 30 203 51 119 285
2025/20262.123 175 169 208 199 258 53 413 93 128 190 104 133
Totale 3.683